Tumor budding and evidence-based treatment of T2 rectal carcinomas

Journal of Surgical Oncology

Volumn 92, Issue 1, 2005, Pages 59-63

  Masaki, Tadahiko ^a   Matsuoka, Hiroyoshi ^a   Sugiyama, Masanori ^a   Abe, Nobutsugu ^a   Sakamoto, Atsuhiko ^a   Watanabe, Toshiaki ^b   Nagawa, Hirokazu ^b   Atomi, Yutaka ^a  

^a KYORIN UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Decision analysis; Local excision; Lymph node metastasis; T2 rectal carcinoma; Tumor budding

Indexed keywords

ADULT; ARTICLE; EXCISION; FEMALE; HUMAN; HUMAN TISSUE; LIFE EXPECTANCY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; RECTUM CARCINOMA; RECTUM RESECTION; REGRESSION ANALYSIS;

CELL DIFFERENTIATION; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; RECTAL NEOPLASMS; REGRESSION ANALYSIS; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 26444519951     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.20369     Document Type: Article

References (26)

1. Lockhart-Mummery HE, Dukes CE: The surgical treatment of malignant polyps. Lancet 1952;2:751-756.
2. Morson BC, Bussey HJR, Samoorian S: Policy of local excision for early cancer of the colorectum. Gut 1977;18:1045-1050.
3. Lock MR, Ritchie JK, Hawley PR: Reappraisal of radical local excision for carcinoma of the rectum. Br J Surg 1993;80:928-929.
4. Sterns MW, Jr, Sternberg SS, DeCosse JJ: Treatment alternatives-Localized rectal cancer. Cancer 1984;54:2691-2694.
5. Masaki T, Sugiyama M, Atomi Y, et al.: The indication of local excision for T2 rectal carcinomas. Am J Surg 2001;181:133-137.
6. Rich TA, Weiss DR, Mies C, et al.: Sphincter preservation in patients with low rectal cancer treated with radiation therapy with or without local excision or fulguration. Radiology 1985;156:527-531.
7. Steele G, Jr, Busse P, Huberman MS, et al.: A pilot study of sphincter-sparing management of adenocarcinoma of the rectum. Arch Surg 1991;126:696-702.
8. Minsky BD, Cohen AM, Enker WE, et al.: Sphincter preservation in rectal cancer by local excision and postoperative radiation therapy. Cancer 1991;67:908-914.
9. Minsky BD: Clinical experience with local excision and post-operative radiation therapy for rectal cancer. Dis Colon Rectum 1993;36:405-409.
10. Rosenthal SA, Yeung RS, Weese JL, et al.: Conservative management of extensive low-lying rectal carcinomas with transanal local excision and combined preoperative and post-operative radiation therapy. A report of a phase I-II trial. Cancer 1992;69:335-341.
11. Wong CS, Stern H, Cummings BJ: Local excision and post-operative radiation therapy for rectal carcinoma. Int J Radiat Oncol Biol Phys 1993;25:669-675.
12. Garcia-Aguilar J, Mellgren A, Sirivongs P, et al.: Local excision of rectal cancer without adjuvant therapy: A word of caution. Ann Surg 2000;231:345-351.
13. Goldstein NS, Hart J: Histologic features associated with lymph node metastasis in Stage T1 and superficial T2 rectal adenocarcinomas in abdominoperineal resection specimens. Identifying a subset of patients for whom treatment with adjuvant or completion abdominoperineal resection should be considered after local excision. Am J Clin Pathol 1999;111:51-58.
14. Okuyama T, Oya M, Ishikawa H: Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma. Dis Colon Rectum 2002;45:628-634.
15. Morson BC, Sobin LH: Histological typing of intestinal tumours. Geneva: World Health Organization, 1976.
16. Registry Committee, Japanese Society for Cancer of the Colon and Rectum. Multi-institutional registry of large bowel cancer in Japan. Vol. 1-23(1-6 in Japanese and 7-23 in English). Utsunomiya: Registry Committee, 1985-2002.
17. Cunningham JD, Enker W, Cohen A: Salvage therapy for pelvic recurrence following curative rectal cancer resection. Dis Colon Rectum 1997;40:393-400.
18. Temple LKF, Naimark D, McLeod RS: Decision analysis as an aid to determining the management of early low rectal cancer for the individual patient. J Clin Oncol 1999;17:312-318.
19. Tepper JE, Hollis CD, Niedwiecki D, et al.: Analysis of surgical salvage after failure of primary therapy in rectal cancer: Results from Intergroup Study 0114. J Clin Oncol 2003;21:3623-3628.
20. Paty PB, Nash GM, Baron P, et al.: Long-term results of local excision for rectal cancer. Ann Surg 2002;236:522-529.
21. Coverlizza S, Risio M, Ferrari A, et al.: Colorectal adenomas containing invasive carcinoma. Pathologic assessment of lymph node metastatic potential. Cancer 1989;64:1937-1947.
22. Morodomi T, Isomoto H, Shirouzu K, et al.: Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 1989;63:539-543.
23. Hase K, Shatney C, Johnson D, et al.: Prognostic value of tumor "budding" in patients with colorectal cancer. Dis Colon Rectum 1993;36:627-635.
24. Ono M, Sakamoto M, Ino Y, et al.: Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis. Cancer 1996;78:1179-1186.
25. Tanaka S, Haruma K, Teixeira CR, et al.: Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis. J Gastroenterol 1995;30:710-717.
26. Ueno H, Murphy J, Jass JR, et al.: Tumor 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 2002;40:127-132.